Related Experiment Video
Updated: Jul 3, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Lipid and nutritional profiles of Caribbean patients with chronic kidney disease
1Department of Chemical Pathology, Faculty of Clinical Sciences, Bayero University, Kano.
Aim:
Chronic kidney disease (CKD) is marked by the deterioration of kidney function and derangement in lipid metabolism. Thus, we aim at evaluating the lipid and nutritional parameters of Caribbean patients with CKD.
Methods:
The study recruited 88 CKD patients and 105 apparently healthy subjects. Blood glucose, urea, creatinine, albumin, uric acid, total cholesterol, triglycerides, HDL-cholesterol, VLDL, and LDL were measured in duplicate on the Vitros 4600 Multi-Channel Chemistry Auto-Analyzer (Johnson & Johnson Ortho-Clinical Diagnostics Inc., Rochester NY, USA) in our laboratory. The Statistical Package for the Social Sciences (SPSS, version 20) was used for statistical analysis.
Results:
Mean levels of diastolic blood pressure (p < 0.05), age, and systolic blood pressure between the patients and the healthy controls (p < 0.001) were different. In addition, mean levels of BUN (p < 0.05), serum creatinine, and uric acid were higher and eGFR lower in the patients compared with the healthy controls (p < 0.001). The mean levels of albumin, glucose, triglycerides, HDL-cholesterol, and VLDL (p < 0.001) also differed between patients and healthy controls. Negative correlation between eGFR and triglycerides and a positive correlation between eGFR and total cholesterol, HDL-c and LDL were observed. The prevalence of hypoalbuminemia, hypercholesterolemia and underweight were 27.27%, 57.95% and 4.55% respectively in patients, compared with 10.48%, 44.74% and 2.86% respectively in healthy controls.
Conclusion:
Dyslipidemia is common in CKD patients and is therefore, imperative that, routine lipid profile analysis be detailed in order to check any trend towards the development of CVD.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

